(Q35799602)

10 August 2017

1 reference

title

Biomarkers in systemic lupus erythematosus. I. General overview of biomarkers and their applicability (English)

1 reference

systemic lupus erythematosus

10 August 2017

0 references

1 reference

Gabor G Illei

1

1 reference

10 August 2017

Edward Tackey

series ordinal

2

1 reference

10 August 2017

Larissa Lapteva

series ordinal

3

1 reference

10 August 2017

Peter E Lipsky

series ordinal

4

1 reference

10 August 2017

language of work or name

1 reference

1 June 2004

1 reference

10 August 2017

Arthritis & Rheumatology

1 reference

10 August 2017

50

1 reference

10 August 2017

6

1 reference

10 August 2017

1709-1720

1 reference

Overview of biomarkers and surrogate endpoints in drug development

10 August 2017

1 reference

Surrogate end points in clinical trials: are we being misled?

21 January 2018

1 reference

Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus

21 January 2018

1 reference

Fas gene polymorphisms are not associated with systemic lupus erythematosus, multiple sclerosis and HIV infection

21 January 2018

1 reference

A novel polymorphic CAAT/enhancer-binding protein beta element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ART.20344

1 reference

10 August 2017

1 reference